Do I Qualify for a Tepezza Lawsuit?
Most people who ask us this question qualify on the basic criteria. The two things that actually matter are simpler than people expect — and several of the assumptions that stop people from calling turn out to be wrong.
[START MY FREE CASE REVIEW] · [CALL 800-356-4338]
The Two Core Requirements
1. You received Tepezza infusions
Tepezza (teprotumumab-trbw) is given intravenously for thyroid eye disease — also called TED, Graves' eye disease, or Graves' orbitopathy. The standard course is eight infusions given three weeks apart over roughly five months: one initial 10 mg/kg dose followed by seven doses at 20 mg/kg, each running 60 to 90 minutes.
You may have received it at an infusion center, a hospital, your ophthalmologist's office, or at home.
You do not need to have completed all eight. Plaintiffs in this litigation include people who received three infusions before their hearing changed. In the published research, symptoms appeared after an average of roughly 3.6 infusions.
2. You developed a hearing injury
Qualifying injuries include:
- Permanent or partial hearing loss
- Sensorineural hearing loss
- Tinnitus — ringing, buzzing, roaring, or humming in one or both ears
- Deafness
- Autophony — your own voice sounding unnaturally loud, echoing, or hollow
- A persistent plugged or full sensation in the ears
- Hypoacusis (reduced hearing) or hyperacusis (painful sensitivity to sound)
- Patulous eustachian tube or eustachian tube dysfunction
- Muffled or distorted hearing; difficulty following speech in noisy rooms
Symptoms typically begin during the infusion series or in the months following it.
Six Things People Wrongly Assume Disqualify Them
"My hearing loss is only in one ear." Unilateral hearing loss is documented in this litigation. It affects how a case is valued, not whether you have one.
"I only had three or four infusions." See above. Cases have been filed by plaintiffs who received three.
"My tinnitus comes and goes." Intermittent tinnitus is a compensable injury. It may sit at a lower tier than profound permanent hearing loss, but it is a claim.
"I never got a hearing test before treatment." Most patients didn't — because until July 2023 the label didn't tell doctors to order one. That failure is part of what this litigation is about. A post-treatment audiogram plus your own account of what changed is workable evidence.
"I already had some hearing loss before Tepezza." Pre-existing hearing loss does not automatically disqualify you. What matters is whether your hearing measurably worsened, or new symptoms like tinnitus or autophony appeared.
"My doctor said it would go away." Many patients were told that, because that is what the label said. A 2022 study in the American Journal of Ophthalmology found that fewer than half of patients who developed subjective hearing loss had fully recovered eight months after stopping infusions — roughly 20% still had autophony and about 10% still had ear-plugging symptoms.
What Makes a Tepezza Case Stronger
None of these are requirements. They are the factors that tend to increase case value.
An audiogram showing measurable decline. A pre-treatment baseline compared against a post-treatment test is the strongest evidence available in this litigation. Post-treatment testing alone still carries real weight.
Contemporaneous complaints in your medical records. Notes showing you reported ringing, muffled hearing, or ear fullness to your ophthalmologist, endocrinologist, primary care doctor, or infusion nurse during or shortly after treatment.
Treatment before July 17, 2023. Patients infused before the label change received the drug when Tepezza's warnings said nothing about permanent hearing loss and recommended no hearing monitoring. This is the cleanest version of the failure-to-warn claim.
Documented permanence. Symptoms persisting six months or more after your final infusion, or an audiologist's assessment that the loss is not expected to recover.
Treatment or devices you now need. Hearing aids, cochlear implants, tinnitus retraining therapy, ongoing audiology care — each represents documented economic damages.
Occupational impact. If your work depends on hearing — teaching, medicine, music, trades, customer-facing roles — lost income and diminished earning capacity can substantially increase a claim's value.
What If I Was Treated After the Label Changed?
You may still have a claim. Lawsuits have been filed by patients whose treatment began in July 2023, right at the transition. These cases turn on facts specific to you: what your prescribing physician actually knew and communicated, whether the updated warning reached your treating team, whether hearing monitoring was ordered, and whether your consent was meaningfully informed.
Do not rule yourself out based on a date. Let us look at the records.
What About Michigan?
Michigan has a unique history here. A state statute — since repealed, but not retroactively — barred product liability claims involving FDA-approved drugs, and Horizon used it in 2024 to remove one bellwether case from the pool. If you were treated in Michigan, your claim requires an individualized analysis rather than an assumption. Call us.
Is There a Deadline?
Yes — two of them, and they run independently.
The statute of limitations. Every state sets a deadline for product liability claims, typically one to four years, and the clock generally starts when you knew or reasonably should have known your injury was connected to Tepezza. That trigger date is fact-specific and frequently contested. It is not something to estimate on your own.
The practical settlement deadline. This one gets less attention and costs more people their claims. When a global settlement framework is reached in a mass tort, it is built around the population of claims that exists at that moment. Eligibility criteria and registration deadlines get set. People who hadn't filed yet routinely find themselves outside the window.
Trial deadlines in this MDL have been suspended and court-supervised settlement negotiations have been running for over a year. If you are going to file, the time to start is now.
What Happens When You Call
The call itself: about 15 minutes. We'll ask when you were diagnosed with TED, when and where you received infusions, how many you had, what hearing symptoms developed and when, whether you've seen an audiologist, and whether you use hearing aids or other treatment. There is no cost and no obligation.
If we take your case: we obtain your infusion and audiology records ourselves. You are not responsible for chasing down paperwork from providers.
Filing: your claim is filed individually and joins the coordinated federal proceedings. It is not a class action — your case is valued on your own injuries.
Cost: nothing out of pocket, ever. Contingency fee only. We are paid only if you recover.
Helpful to Have Ready (Not Required)
- Approximate dates of your first and last infusion
- Number of infusions received
- Name of the infusion center, hospital, or practice
- Name of the physician who prescribed Tepezza
- When your hearing symptoms began
- Whether you've had a hearing test, and roughly when
- Whether you use hearing aids or other hearing devices
If you don't have this handy, call anyway. We can reconstruct most of it from records.
Find Out Where You Stand
[FREE CASE REVIEW] · [CALL 800-356-4338]
Free nationwide consultation, 24/7. No fees unless you win.
ATTORNEY ADVERTISING. Prior results do not guarantee a similar outcome. This page is informational and is not legal advice. Submitting a form does not create an attorney-client relationship.